In fact, the following are the natural phytoconstituent-based drugs that have been accepted clinically in AD, such as cholinesterase inhibitors (tacrine, galantamine, donepezil, and rivastigmine) and glutamatergic system modulators (memantine). This evidence concerns the gene BCHE and Alzheimer disease.